Mechanism of Masked Hypertension - Intervention

Summary

To test the hypothesis that sympatholytic antihypertensive antihypertensive therapy (αβ-blocker - carvedilol) will reduce out-of-clinic ambulatory BP to a greater extent by blocking sympathetic activity than non-sympatholytic antihypertensive medication (dihydropyridine calcium channel blocker - amlodipine) in individuals with masked hypertension.

Timeline

Start

2021-07

Primary completion

2026-06

Completion

2026-06

Drugs

Indications